Image

Global Peripheral Neuropathy Market – Industry Trends and Forecast to 2029

Pharmaceutical

Image

Global Peripheral Neuropathy Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Peripheral Neuropathy Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 262.69 USD Million
Diagram Market Size (Forecast Year) USD 373.61 USD Million
Diagram CAGR %

Major Markets Players

  • Teikoku Pharma
  • Sun Pharmaceutical Industries
  • Galen Limited
  • Cipher Pharmaceuticals
  • Mylan

Global Peripheral Neuropathy Market, By Treatment (Pain Relievers, Anti-Seizure Medications, Antidepressants, Others), Therapy Type (Transcutaneous Electrical Nerve Stimulation (TENS), Physical Therapy, Immunoglobulins, Others), Route of Administration (Oral, Parenteral, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) - Industry Trends and Forecast to 2029

Peripheral Neuropathy Market

Market Analysis and Insights

Peripheral nervous system is known to connect the nerves from the spinal cord and brain, or central nervous system to the rest of your body. Peripheral neuropathy refers to the disorder caused due to the damage to the spinal cord (peripheral nerves) and nerves outside of the brain. The disorder causes numbness and pain, also weakness in your hands and feet.

  • The disease often occurs due to variety of systemic diseases, medications, toxic exposures, hereditary disorders and infections. Global peripheral neuropathy market was valued at USD 262.69 million in 2021 and is expected to reach USD 373.61 million by 2029, registering a CAGR of 4.4% during the forecast period of 2022-2029.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Pain Relievers, Anti-Seizure Medications, Antidepressants, Others), Therapy Type (Transcutaneous Electrical Nerve Stimulation (TENS), Physical Therapy, Immunoglobulins, Others), Route of Administration (Oral, Parenteral, Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Market Players Covered

Teikoku Pharma USA, Inc (US), Sun Pharmaceutical Industries Ltd (India), Galen Limited (US), Cipher Pharmaceuticals Inc (Canada), Mylan N.V. (US), Aurobindo Pharma (India), ZydusCadila (India), Hikma Pharmaceuticals PLC (UK), ACI Limited (Bangladesh), Apotex Inc (Canada), Johnson & Johnson Services, Inc (US), Pfizer Inc (US), Arbor Pharmaceuticals (US), ALMATICA PHARMA (India), Alkem Labs (India), Amneal Pharmaceuticals LLC (US), Novartis AG (Switzerland), and Lupin, among others

Peripheral Neuropathy Market Dynamics

Drivers

  • Prevalence of Diabetes

The rise in the prevalence of diabetes across the globe acts as one of the major factor driving the growth of peripheral neuropathy market.

  • Increase In Mergers and Acquisitions

The increase in the number of mergers and acquisitions among manufacturers and research organizations to provide efficient medical care to patients and generate significant revenues by their sales options results in the expansion of the market.

  • Chemotherapy Treatments

The rise in the number of chemotherapy treatments accelerate the market growth. Medications and side-effects associated with various treatments could also lead to peripheral neuropathy.

  • Financial support to the researchers for developing novel intervention

Various public and private organizations are increasing their investments in developing novel interventions and treatments further influence the market.

Additionally, surge in healthcare expenditure, increase in demand for effective therapies, and development in technology positively affect the peripheral neuropathy market.

Opportunities

Furthermore, development of novel treatment extends profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, rise in awareness about peripheral neuropathy will escalate the growth of peripheral neuropathy market growth.

Restraints/Challenges

On the other hand, adverse effects associated with drugs and stringent regulatory policies are expected to obstruct the market growth. The generic competitions of drugs are projected to challenge the peripheral neuropathy market in the forecast period of 2022-2029.

This peripheral neuropathy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on peripheral neuropathy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The peripheral neuropathy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Peripheral Neuropathy Market

The COVID-19 negatively impacted the peripheral neuropathy market. The outbreak of the pandemic caused disruption in the supply chains of the drugs that lead to supply gaps for countries dependent on trade affairs for drugs. However, the supply chain disruptions and logistics are being eased in the post-second wave.

Global Peripheral Neuropathy Market

The peripheral neuropathy market is segmented on the basis of treatment, therapy type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Pain Relievers
  • Anti-Seizure Medications
  • Antidepressants
  • Others

On the basis of treatment, the peripheral neuropathy market is segmented into pain relievers, anti-seizure medications, antidepressants and others.

Therapy Type

  • Transcutaneous Electrical Nerve Stimulation (TENS)
  • Physical Therapy
  • Immunoglobulins
  • Others

The therapy type segment for peripheral neuropathy market includes transcutaneous electrical nerve stimulation (TENS), physical therapy, immunoglobulins and others.

Route of Administration

  • Oral
  • Parenteral
  • Others

Route of administration segment of peripheral neuropathy market is segmented into oral, parenteral and others.

End-Users

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

On the basis of end-users, the peripheral neuropathy market is segmented into hospitals, homecare, specialty clinics and others.

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

On the basis of distribution channel, the peripheral neuropathy market has been bifurcated into hospital pharmacy, online pharmacy and retail pharmacy.

Pipeline Analysis

Off-label prescription of several is widespread, with a limited number of prescription drugs available for neuropathic pain. Teikoku Pharma USA, Inc, Sun Pharmaceutical Industries Ltd, Galen Limited, and Cipher Pharmaceuticals Inc, among others are some of the manufacturers involved with the development of peripheral neuropathy.

Peripheral Neuropathy Market Regional Analysis/Insights

The peripheral neuropathy market is analysed and market size insights and trends are provided by country, treatment, therapy type, route of administration, end-users and distribution channel as referenced above.

The countries covered in the peripheral neuropathy market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the peripheral neuropathy market due to the increasing prevalence of diabetes and cancer within the region.

Asia-Pacific is expected to witness high growth during the forecast period of 2022 to 2029 because of the growing number of geriatric populations in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Peripheral Neuropathy Market Share Analysis

The peripheral neuropathy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to peripheral neuropathy market.

Some of the major players operating in the peripheral neuropathy market are Teikoku Pharma USA, Inc (US), Sun Pharmaceutical Industries Ltd (India), Galen Limited (US), Cipher Pharmaceuticals Inc (Canada), Mylan N.V. (US), Aurobindo Pharma (India), ZydusCadila (India), Hikma Pharmaceuticals PLC (UK), ACI Limited (Bangladesh), Apotex Inc (Canada), Johnson & Johnson Services, Inc (US), Pfizer Inc (US), Arbor Pharmaceuticals (US), ALMATICA PHARMA (India), Alkem Labs (India), Amneal Pharmaceuticals LLC (US), Novartis AG (Switzerland), and Lupin , among others.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Global Peripheral Neuropathy Market was valued at USD 262.69 million in 2021 and is expected to reach USD 373.61 million by 2029
Global Peripheral Neuropathy Market is expected to witness CAGR of 4.4% during the forecast period of 2022-2029
The rise in prevalence of chronic diseases among population, surge in healthcare expenditure, increase in demand for effective therapies are escalating the market growth.
Teikoku Pharma USA, Inc (US), Sun Pharmaceutical Industries Ltd (India), Galen Limited (US), Cipher Pharmaceuticals Inc (Canada), Mylan N.V. (US), Aurobindo Pharma (India), ZydusCadila (India), Hikma Pharmaceuticals PLC (UK), ACI Limited (Bangladesh), Apotex Inc (Canada), Johnson & Johnson Services, Inc (US), Pfizer Inc (US), Arbor Pharmaceuticals (US), ALMATICA PHARMA (India), Alkem Labs (India), Amneal Pharmaceuticals LLC (US), Novartis AG (Switzerland), and Lupin , among others.
The countries covered in the peripheral neuropathy market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials